Cargando…

Diabetic polyneuropathy is a risk factor for decline of lower extremity strength in patients with type 2 diabetes

AIMS/INTRODUCTION: The present study elucidated the effect of diabetic polyneuropathy (DPN) on lower extremity strength in a wide age range of type 2 diabetes patients. MATERIALS AND METHODS: Participants (n = 1,442) were divided into three age groups (30–49 years, 50–69 years and 70–87 years), and...

Descripción completa

Detalles Bibliográficos
Autores principales: Nomura, Takuo, Ishiguro, Tomoyasu, Ohira, Masayoshi, Ikeda, Yukio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5754538/
https://www.ncbi.nlm.nih.gov/pubmed/28296226
http://dx.doi.org/10.1111/jdi.12658
_version_ 1783290437614698496
author Nomura, Takuo
Ishiguro, Tomoyasu
Ohira, Masayoshi
Ikeda, Yukio
author_facet Nomura, Takuo
Ishiguro, Tomoyasu
Ohira, Masayoshi
Ikeda, Yukio
author_sort Nomura, Takuo
collection PubMed
description AIMS/INTRODUCTION: The present study elucidated the effect of diabetic polyneuropathy (DPN) on lower extremity strength in a wide age range of type 2 diabetes patients. MATERIALS AND METHODS: Participants (n = 1,442) were divided into three age groups (30–49 years, 50–69 years and 70–87 years), and comparisons were made separately for each sex. Lower extremity strength was measured in terms of knee extension force (KEF) with a hand‐held dynamometer. KEF was compared according to the presence or absence of DPN. Furthermore, the effect of DPN on KEF with other diabetic complications (diabetic retinopathy and diabetic nephropathy), diabetes status (diabetes duration and glycated hemoglobin) and habitual behavior (regular exercise, smoking and drinking behaviors) as explanatory variables was analyzed using multiple regression analysis in several models. RESULTS: The frequency of DPN differed among age groups, ranging from 14.3 to 49.6%, and increasing with age. There was no significant difference in KEF between patients aged 30–49 years with and without DPN. However, among both men and women aged 50–69 years and 70–87 years, patients with DPN showed significantly diminished KEF (11.0–12.9% and 11.9–16.6%, respectively) compared with those without DPN (P < 0.01–0.001). In women aged 50–69 years and 70–87 years, and in men aged 50–69 years, DPN was a significant explanatory variable for KEF in all multiple regression analysis models. CONCLUSION: DPN might reinforce a KEF decline in middle‐aged and elderly type 2 diabetes patients.
format Online
Article
Text
id pubmed-5754538
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-57545382018-01-09 Diabetic polyneuropathy is a risk factor for decline of lower extremity strength in patients with type 2 diabetes Nomura, Takuo Ishiguro, Tomoyasu Ohira, Masayoshi Ikeda, Yukio J Diabetes Investig Articles AIMS/INTRODUCTION: The present study elucidated the effect of diabetic polyneuropathy (DPN) on lower extremity strength in a wide age range of type 2 diabetes patients. MATERIALS AND METHODS: Participants (n = 1,442) were divided into three age groups (30–49 years, 50–69 years and 70–87 years), and comparisons were made separately for each sex. Lower extremity strength was measured in terms of knee extension force (KEF) with a hand‐held dynamometer. KEF was compared according to the presence or absence of DPN. Furthermore, the effect of DPN on KEF with other diabetic complications (diabetic retinopathy and diabetic nephropathy), diabetes status (diabetes duration and glycated hemoglobin) and habitual behavior (regular exercise, smoking and drinking behaviors) as explanatory variables was analyzed using multiple regression analysis in several models. RESULTS: The frequency of DPN differed among age groups, ranging from 14.3 to 49.6%, and increasing with age. There was no significant difference in KEF between patients aged 30–49 years with and without DPN. However, among both men and women aged 50–69 years and 70–87 years, patients with DPN showed significantly diminished KEF (11.0–12.9% and 11.9–16.6%, respectively) compared with those without DPN (P < 0.01–0.001). In women aged 50–69 years and 70–87 years, and in men aged 50–69 years, DPN was a significant explanatory variable for KEF in all multiple regression analysis models. CONCLUSION: DPN might reinforce a KEF decline in middle‐aged and elderly type 2 diabetes patients. John Wiley and Sons Inc. 2017-05-06 2018-01 /pmc/articles/PMC5754538/ /pubmed/28296226 http://dx.doi.org/10.1111/jdi.12658 Text en © 2017 The Authors. Journal of Diabetes Investigation published by Asian Association for the Study of Diabetes (AASD) and John Wiley & Sons Australia, Ltd This is an open access article under the terms of the Creative Commons Attribution‐NonCommercial‐NoDerivs (http://creativecommons.org/licenses/by-nc-nd/4.0/) License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made.
spellingShingle Articles
Nomura, Takuo
Ishiguro, Tomoyasu
Ohira, Masayoshi
Ikeda, Yukio
Diabetic polyneuropathy is a risk factor for decline of lower extremity strength in patients with type 2 diabetes
title Diabetic polyneuropathy is a risk factor for decline of lower extremity strength in patients with type 2 diabetes
title_full Diabetic polyneuropathy is a risk factor for decline of lower extremity strength in patients with type 2 diabetes
title_fullStr Diabetic polyneuropathy is a risk factor for decline of lower extremity strength in patients with type 2 diabetes
title_full_unstemmed Diabetic polyneuropathy is a risk factor for decline of lower extremity strength in patients with type 2 diabetes
title_short Diabetic polyneuropathy is a risk factor for decline of lower extremity strength in patients with type 2 diabetes
title_sort diabetic polyneuropathy is a risk factor for decline of lower extremity strength in patients with type 2 diabetes
topic Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5754538/
https://www.ncbi.nlm.nih.gov/pubmed/28296226
http://dx.doi.org/10.1111/jdi.12658
work_keys_str_mv AT nomuratakuo diabeticpolyneuropathyisariskfactorfordeclineoflowerextremitystrengthinpatientswithtype2diabetes
AT ishigurotomoyasu diabeticpolyneuropathyisariskfactorfordeclineoflowerextremitystrengthinpatientswithtype2diabetes
AT ohiramasayoshi diabeticpolyneuropathyisariskfactorfordeclineoflowerextremitystrengthinpatientswithtype2diabetes
AT ikedayukio diabeticpolyneuropathyisariskfactorfordeclineoflowerextremitystrengthinpatientswithtype2diabetes